Joint ISDA/GFMA letter regarding the mandated use of ISIN for product identification under MIFID II/MIFIR

On December 15, 2015, ISDA and GFMA sent a letter to the European Commission highlighting two major concerns related to the mandated use of ISINs for OTC derivatives. The first one relates to the applicability of ISIN for derivatives and derivatives processing as a product identifier. The second relates to competition issues that will be created by a mandated adoption of ISIN.

Tags:

Documents (1) for Joint ISDA/GFMA letter regarding the mandated use of ISIN for product identification under MIFID II/MIFIR

ISDA AGM Studio: José Manuel Campa, EBA

José Manuel Campa, chairperson of the European Banking Authority, speaks to Mark Gheerbrant, ISDA’s global head of risk and capital, about concerns over differences in timing and content of the Basel III reforms across jurisdictions and what can be done...

ISDA AGM Studio: Doug Donahue and Oliver Maxwell

Just a small delay in the delivery and receipt of a termination notice can have significant economic consequences for derivatives counterparties. Doug Donahue, partner at Linklaters, and Oliver Maxwell, product management director, platforms and regulatory compliance at S&P Global Market...